Ownership; Inventions. ALZA will own and retain and will continue to own and retain, all rights, title and interest to (i) any inventions conceived and reduced to practice by employees of ALZA, or by or on behalf of ALZA by Third Parties, prior to the Effective Date, including the Licensed Patents, and (ii) all ALZA Inventions, even if conceived by or on behalf of ALZA, prior to the Effective Date and reduced to practice by TMC after the Effective Date. Any invention conceived and reduced to practice and arising out of work conducted by or on behalf of a Party after the Effective Date that relates primarily to Microprojection Systems (including the use or manufacture thereof), including, but not limited to, Future ALZA Inventions and TMC Inventions, will (i) be owned by that Party and that Party will retain all rights, title and interest to the invention subject to the terms of this Agreement, including the right to file patent applications based on the invention and to prosecute; issue and maintain Patents that issue based on such Party’s invention, or (ii) if owned by a Third Party, will be licensed to the applicable Party under terms permitting such Party to fulfill its obligations to the other Party under Sections 2.1.1(b) or 2.2, as applicable. For purposes of clarity, inventorship for patentable inventions will be determined in accordance with United States patent laws for determining inventorship. In the event of a dispute regarding inventorship, if the Parties are unable to resolve such inventorship dispute, the Parties will establish a procedure to resolve such dispute, which may include engaging a Third Party patent attorney jointly selected by the Parties to resolve such dispute.
Ownership; Inventions. Licensee shall own and retain all rights, title, and interest in and to Inventions and Improvements created by Licensee arising after the Effective Date. Licensor shall have no license, right, or interest whatsoever in or to any and all such Licensee Inventions and Improvements, except as expressly set forth in this Agreement.
Ownership; Inventions. Licensee and Licensor acknowledge that performance of this Agreement may result in the development of new concepts, methods, techniques, data, know-how, processes, adaptations, ideas and expressions of ideas.
(a) INVENTIONS RELATING TO PHARMACEUTICAL COMPOUNDS AND LICENSEE SOFTWARE. Concepts, methods, techniques, data, know-how, processes, adaptations, compounds, compositions of matter, ideas and expressions of ideas relating to pharmaceuticals developed by or on behalf of Licensee ("Pharmaceutical Know-How") and any Licensee Software developed by or on behalf of Licensee prior to or during the course of this Agreement shall be and remain the exclusive property of Licensee. Licensor shall have no right and no title or ownership of any component or manifestation of any such Pharmaceutical Know-How, Proprietary Components of Custom Software Modules, Licensee Software or resulting pharmaceutical product developed by or on behalf of Licensee. All rights in such Pharmaceutical Know-How, Proprietary Components of Custom Software Modules, Licensee Software or resulting pharmaceutical products are and shall remain the exclusive property of Licensee. Concepts, methods, techniques, data, know-how, processes, adaptations, ideas and expressions of ideas relating to Licensee Software or Proprietary Components of Custom Software Modules that incorporate any Licensor Intellectual Property or Licensor Confidential Information, shall be used by Licensee exclusively in conjunction with the System. Licensee Software shall be owned by Licensee and Licensor shall only have right to use Licensee Software for the benefit of Licensee for the purposes set forth in this Agreement. Licensee grants to Licensor a non-exclusive, nontransferable right to use Licensee Software at the Designated Locations in connection with the System and Services provided in this Agreement.
(b) INVENTIONS RELATING TO LICENSED SOFTWARE, HARDWARE AND CUSTOM SOFTWARE MODULES (OTHER THAN PROPRIETARY COMPONENTS OF CUSTOM SOFTWARE MODULES). Concepts, methods, techniques, know-how, processes, adaptations, ideas and expressions of ideas relating to the Licensed Software or any Custom Software Module developed by or on behalf of Licensor during the course of this Agreement shall be and remain the exclusive property of Licensor provided, however, that (i) Licensor grants to Licensee a non-exclusive, nontransferable right to use the Custom Software Module at the Designated Location(s) under the terms and conditions...
Ownership; Inventions. 30 11.2 Prosecution and Maintenance of Patent Rights......................32 11.3 Prosecution and Maintenance of Joint Targets, Joint Lead Compounds, Joint Safety Assessment Compounds and Joint Development Compounds.............................................32 11.4 Cooperation.......................................................33
Ownership; Inventions. Pulmatrix shall own and retain all rights, title, and interest in and to inventions created by Pulmatrix after the Effective Date. RespiVert shall have no license, right, or interest whatsoever in or to any and all such Pulmatrix inventions, except as expressly set forth in this Agreement.
Ownership; Inventions. Inventorship for patentable inventions conceived and reduced to practice during the course of the performance of activities pursuant to this Agreement shall be determined in accordance with U.S. patent laws for determining inventorship. Ownership shall be determined based on inventorship. **Certain portions of this exhibit have been omitted based upon a request for confidential treatment that has been filed with the Commission. The omitted portions have been filed separately with the Commission. In the event of a dispute regarding inventorship, if the parties are unable to resolve such inventorship dispute, the Parties shall establish a procedure to resolve such dispute, which may include engaging a Third Party patent attorney jointly selected by the Parties to resolve such dispute.
Ownership; Inventions. 12.1 All information received from NeoStem or obtained or delivered to NeoStem as a result of HemaCare's performance of Services hereunder ("NeoStem Information") shall be the sole property of NeoStem and NeoStem shall be free to disclose and use the NeoStem Information, regardless of origin, for any purpose.
12.2 Any new knowledge or inventions that are developed from the collection of a NeoStem client shall be the sole property of NeoStem and NeoStem shall be free to file the appropriate applications for patent protection, orphan drug status or other regulatory exemptions.
Ownership; Inventions. 5.1 No rights of any nature in, to, or over any Material shall be deemed to be conferred on the Recipient by this Agreement.
5.2 All Material outlined in Appendix I, and including Material contained or incorporated in Modifications shall remain the property of Trinity.
5.3 The Recipient retains ownership of Inventions, except that Trinity retains ownership rights to the Material included therein, and Trinity reserves the right to request the use of such Inventions for internal research, teaching and non-commercial purposes only. The Recipient shall in good faith notify Trinity forthwith of Inventions created by the Recipient that incorporates the Material or a portion of the Material. The management, ownership, proposed commercial exploitation of such Inventions shall be discussed in good faith by the Parties taking into consideration each Party’s intellectual contribution and the provision of the Materials in creating the Inventions.
Ownership; Inventions. Inventorship for patentable inventions conceived and reduced to practice during the course of the performance of activities pursuant to this Agreement shall be determined in accordance with U.S. patent laws for determining inventorship. Xxxxxxx Patents shall be owned by Xxxxxxx, 3DP Patents shall be owned by 3DP, and Joint Patents shall be jointly owned by the Parties. Research Program Patent Rights shall be owned by 3DP, regardless of inventorship, and Xxxxxxx agrees to assign to 3DP its rights in any Research Program Patent Rights having Xxxxxxx employees as sole or joint inventors. In the event of a dispute regarding inventorship, if the parties are unable to resolve such inventorship dispute, the Parties shall establish a procedure to resolve such dispute, which may include engaging a Third Party patent attorney jointly selected by the Parties to resolve such dispute. Each Party will cooperate with the other to the extent reasonably necessary to execute assignments and other documentation as may be required.
Ownership; Inventions. (a) All CRFs and other reports submitted to SPONSOR and all information, documents and raw data collected or generated in connection with this Agreement (“Study Data”), excluding patient records or any other third party proprietary information shall be the sole property of SPONSOR and may be used by SPONSOR for any purpose without further obligation or liability to PAREXEL.
(b) PAREXEL, the Principal Investigator, any Subinvestigators and all other Study personnel engaged to perform the Study under this Agreement shall promptly disclose to SPONSOR any and all discoveries or inventions that are conceived or first reduced to practice or demonstrated to have utility by them in the performance of the Study (“Inventions”). All right, title and interest in and to all Inventions, whether or not patentable or subject to copyright, shall be the exclusive property of SPONSOR, and PAREXEL, the Principal Investigator, any Subinvestigators or other Study personnel shall assign, and hereby assigns, to the SPONSOR all of its, his or her rights and interests in and to all Inventions, and shall cooperate with the SPONSOR in all reasonable respects to assure that ownership of all Inventions accrues to the SPONSOR including, but not limited to, signing applications for letters patent, trademarks and copyrights, assignments, or other necessary or similar documents. PAREXEL represents and warrants that all its employees (including, without limitation, the Principal Investigator, any Subinvestigators and all other Study personnel engaged to perform the Study) are required to execute assignment of inventions agreements on behalf of PAREXEL, upon hiring by PAREXEL.
(c) Notwithstanding Section F-4(b) above, SPONSOR acknowledges that all confidential or proprietary testing methods, practices, computer programs, techniques, processes, tools, or equipment, and other materials and ideas developed by or for PAREXEL and solely used by PAREXEL in performance of the Services under this Agreement, which are not either supplied to PAREXEL by Sponsor or related in any way to the Study, Study Drug, Study Materials or other SPONSOR product, technology or know-how (the “PAREXEL Developments and Processes”), other than any of such PAREXEL Developments and Processes which relate exclusively to the matters or substances studied hereunder, and except to the extent any of such PAREXEL Developments and Processes contain information of SPONSOR required to be kept confidential hereunder, shall be and r...
